Oncogene-targeted antisense oligonucleotides for the treatment of Ewing sarcoma

ISSN： 1472-8222

Source： Expert Opinion on Therapeutic Targets, Vol.9, Iss.4, 2005-08, pp. : 825-830

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Antisense Oligonucleotides for the Treatment of Dyslipidemia

Current Pharmaceutical Design, Vol. 17, Iss. 9, 2011-03 ,pp. : 950-960

Bentham Science Publishers

Access to resources Recommend Favorite

Antisense oligonucleotides as drugs for HIV treatment

By Galderisi U Cipollaro M Cascino A

Expert Opinion on Therapeutic Patents, Vol. 11, Iss. 10, 2001-10 ,pp. : 1605-1611

Informa Healthcare

Access to resources Recommend Favorite

Oligonucleotides Targeted Against a Junction Oncogene Are Made Efficient by Nanotechnologies

By Maksimenko A. Malvy C. Lambert G. Bertrand J-R. Fattal E. Maccario J. Couvreur P.

Pharmaceutical Research, Vol. 20, Iss. 10, 2003-10 ,pp. : 1565-1567

Springer Publishing Company

Access to resources Recommend Favorite

Emerging Chemotherapeutic Strategies and the Role of Treatment Stratification in Ewing Sarcoma

By Seddon Beatrice M. Whelan Jeremy S.

Pediatric Drugs, Vol. 10, Iss. 2, 2008-01 ,pp. : 93-105

Adis International

Access to resources Recommend Favorite

Potential therapeutic application of antisense oligonucleotides in the treatment of ocular diseases

By Henry S.P. Danis R.P.

Expert Opinion on Pharmacotherapy, Vol. 2, Iss. 2, 2001-02 ,pp. : 277-291

Informa Healthcare

Access to resources Recommend Favorite